Recombinant Proteins

Recombinant proteins are available as monomers, dimers, trimers, and multimers. Full-length and partial-length proteins are available for control experiments, assay development, and antibody development projects. Utilization of E.coli, mammalian, yeast, and baculovirus expression systems with various activity assays performed to ensure functionality. Applications include  CLIA, EIA, IM, Lateral Flow, and WB.

Thousands of recombinant proteins are available with custom protein expression services available for difficult or hard-to-source targets.

Product Type
Research Area
Host Species
Species Reactivity
Tested Applications
Product Badges
SARS-CoV-2 (COVID-19) NSP9 Recombinant Protein
List Size:
0.1 mg
SARS-CoV-2 (COVID-19) NTD Recombinant Protein
Tested Applications:
ELISA
List Size:
0.1 mg
SARS-CoV-2 (Covid-19) nucleocapsid (N) (insect cell) Recombinant Protein
Tested Applications:
CLIA, ELISA, Lateral Flow, WB
List Size:
0.1 mg
SARS-CoV-2 (Covid-19) nucleocapsid (N) (Omicron, B.1.1.529) Recombinant Protein
Tested Applications:
CLIA, ELISA, Lateral Flow, WB
List Size:
0.1 mg
SARS-CoV-2 (Covid-19) nucleocapsid (N) Recombinant Protein
Tested Applications:
CLIA, ELISA, Lateral Flow, WB
List Size:
0.1 mg
SARS-CoV-2 (COVID-19) Nucleocapsid (N) Recombinant Protein
Tested Applications:
ELISA, WB
List Size:
0.1 mg
List Size:
0.05 mg
SARS-CoV-2 (COVID-19) Nucleocapsid Recombinant Protein
List Size:
1 mg
List Size:
0.05 mg
SARS-CoV-2 (COVID-19) Nucleocapsid Recombinant Protein
List Size:
0.1 mg